Northwestern Mutual Wealth Management
ACAD icon

Northwestern Mutual Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7K Buy
622
+536
+623% +$11.8K ﹤0.01% 2963
2026
Q1 		$1.91K Hold
86
– – ﹤0.01% 3609
2025
Q4 		$2.3K Sell
86
-8
-9% -$191 ﹤0.01% 3449
2025
Q3 		$2.01K Sell
94
-14
-13% -$331 ﹤0.01% 3385
2025
Q2 		$2.33K Buy
+108
New +$2.01K ﹤0.01% 3221
2025
Q1 		– Sell
-26
Closed -$477 – 3649
2024
Q4 		$477 Buy
26
+6
+30% +$97 ﹤0.01% 3388
2024
Q3 		$308 Buy
+20
New +$334 ﹤0.01% 3395
2023
Q3 		– Sell
-100
Closed -$2.4K – 3268
2023
Q2 		$2.4K Buy
+100
New +$2.22K ﹤0.01% 2955
2020
Q3 		– Sell
-100
Closed -$5K – 2512
2020
Q2 		$5K Hold
100
– – ﹤0.01% 2058
2020
Q1 		$4K Hold
100
– – ﹤0.01% 2100
2019
Q4 		$4K Sell
100
-48
-32% -$2.09K ﹤0.01% 2103
2019
Q3 		$5K Buy
+148
New +$4.49K ﹤0.01% 2082
2018
Q2 		– Sell
-8
Closed – – 2344
2018
Q1 		$0 Buy
+8
New +$221 ﹤0.01% 2172
2017
Q1 		– Sell
-149
Closed -$5K – 1983
2016
Q4 		$5K Buy
149
+101
+210% +$2.67K ﹤0.01% 1826
2016
Q3 		$2K Buy
+48
New +$1.63K ﹤0.01% 1914
2013
Q4 		– Sell
-312
Closed -$9K – 1367
2013
Q3 		$9K Hold
312
– – ﹤0.01% 891
2013
Q2 		$6K Buy
+312
New +$4.3K ﹤0.01% 919

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northwestern Mutual Wealth Management's ACAD Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Acadia Pharmaceuticals (ACAD) stake by 623% in Q2 2026, buying an estimated $11.8K and bringing the position to 622 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Northwestern Mutual Wealth Management first reported a position in ACAD in Q2 2013 and has held it in 17 quarters since. 353 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Northwestern Mutual Wealth Management held 622 shares of Acadia Pharmaceuticals worth $15.7K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 536 Acadia Pharmaceuticals shares in Q2 2026, an estimated $11.8K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2963 holding.
  • Northwestern Mutual Wealth Management first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • 353 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.